Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This article discusses potential links between male balding, specifically androgenic alopecia, and severe COVID-19, suggesting that balding may serve as a biomarker for identifying higher-risk patients, but it reports no new experimental findings.

This review summarizes current knowledge of Dermatitis Cruris Pustulosa et Atrophicans, reports its first known case in Bangladesh and Europe, and highlights the need for more research on its etiology and treatment.

This article discusses the interaction between menopause and rheumatic diseases, emphasizing the need for rheumatologists to recognize menopausal symptoms and consider hormone replacement therapy in patient care, but it provides no new experimental results.

This chapter reviews the hair follicle's role in drug and chemical penetration through the skin but does not present new experimental findings.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

In this study, researchers found that minoxidil sulfate enhances the anti-inflammatory effects of the JAK inhibitor baricitinib in alopecia areata, modulating inflammatory signals and preserving immune privilege features in human hair cells, which suggests potential benefits for combined therapy.

This study introduces a novel holistic treatment approach for keloid that combines systemic therapies, including Traditional Chinese Medicine, with local interventions to target the inflammatory microenvironment and keloid predisposition for improved management and prevention of recurrence.

In this preprint, an integrative regenerative protocol involving microneedling, plant-derived exosomes, and other therapies was used to treat androgenetic alopecia in an elderly woman, resulting in improved hair density and scalp coverage.

This preprint reports meaningful improvements in hair density and scalp coverage in an elderly female with androgenetic alopecia treated through an integrative regenerative protocol, involving microneedling and plant-derived exosomes, among other non-pharmacological interventions focusing on cellular senescence pathways.

This study found that many participants with hair loss, or Khalitya, exhibited dietary incompatibilities and low calcium levels, aligning Ayurvedic concepts with modern dietary risk factors.

In this observational study, researchers found that 55% of participants with hair loss known as Khalitya had serum calcium deficiency, which aligns with both Ayurvedic and modern perspectives linking poor nutrition to hair disorder, highlighting the importance of dietary regulation and stress management.

According to this worldwide systematic review, psoriasis is a prevalent disease with adult prevalence ranging from 0.53% to 11.48%, more common in older populations and with substantial knowledge gaps in low and middle-income countries.

In this study, researchers reviewed the evidence linking COVID-19 with dermatologic conditions like androgenetic alopecia and concluded that most proposed associations lack convincing statistical support, challenging the idea of these as independent risk factors for COVID-19 severity.

This source highlights that arsenic exposure through contaminated groundwater is a significant global health risk, leading to skin and hair conditions such as pigmentation changes, skin irritation, alopecia, and can eventually result in skin cancer.

This study found that self-reported alopecia was common in lupus patients, often characterized by changes in hair texture and volume, and was associated with anti-Ro antibodies and significant anxiety.

This article provides an overview of hair loss conditions and treatments, reporting no new research findings.

This review covers medication-induced telogen effluvium with a focus on systemic retinoids, antifungal agents, and psychotropic medications, and reports no new clinical results.

Hair loss should be medically treated, as non-medical treatments are ineffective and hair loss can indicate serious health issues.

This case report describes a 75-year-old woman with pustular psoriasis who developed Beau's lines on her nails, coinciding with episodes of telogen effluvium.

Most hair loss in kids and teens is due to common conditions, and hair usually grows back within 6 months.

Hair loss is common and varies by type, with androgenetic alopecia being the most prevalent.

This review discusses various treatment options for adult female acne, highlighting the need for tailored approaches due to individual patient needs and reports no clinical outcomes.

This article reviews various types of primary cicatricial alopecias and emphasizes the importance of accurate diagnosis to improve management strategies, particularly detailing remaining lymphocytic forms and expanding on neutrophilic and mixed types.

This review highlights the role of keratin mutations in epidermolysis bullosa simplex and the resulting chronic inflammation, but it presents no new experimental findings.

This article describes acute and chronic telogen effluvium, highlighting the importance of differentiating them from androgenetic alopecia for accurate diagnosis and treatment strategies but includes no new clinical research findings.

This review summarizes recent research on the molecular properties and functions of L-PGDS and PGD2, but reports no new findings, highlighting their pathophysiological roles and guiding future studies.

This study found that during the COVID-19 pandemic, there was a significant reduction in dermatology clinic visits, with an increase in stress-induced dermatoses and more male patients seeking dermatological care compared to the previous year.

This article presents a diagnostic case in the Journal of Small Animal Practice and reports no new research findings.

This abstract does not report specific research results but introduces a book focusing on the intersection of endocrinology and aesthetic medicine and its growing importance in contemporary clinical practice.

This correspondence suggests that while patients with Raynaud phenomenon may develop connective tissue disorders, physicians should consider this possibility without assuming for certain that progression will occur.